Disease/Infection News

RSS

Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

An adapted COVID-19 vaccine from Moderna (Spikevax) that targets the Omicron XBB 1.5 subvariant, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

15 Sep 2023

A comprehensive analysis of first monkeypox outbreak in Shenzhen, China

This paper comprehensively analyses the first-ever monkeypox outbreak in Shenzhen, China encompassing clinical symptomatology, therapeutic approaches, epidemiological research, and comprehensive laboratory tests, aiming to establish a robust reference for future mitigation and management strategies for monkeypox.

15 Sep 2023

How does Helicobacter pylori infection influence rheumatoid arthritis?

The association between Helicobacter pylori infection and rheumatoid arthritis (RA).

15 Sep 2023

Can upper respiratory tract specimens be used to diagnose Tuberculosis?

The diagnostic accuracy of upper respiratory tract samples for active pulmonary tuberculosis (TB).

15 Sep 2023

A new covid booster is here. Will those at greatest risk get it?

The Centers for Disease Control and Prevention recommends new covid-19 booster vaccines for all — but many who need them most won't get them. About 75% of people in the United States appear to have skipped last year's bivalent booster, and nothing suggests uptake will be better this time around.

15 Sep 2023

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Shared genetic markers and immune system involvement in sJRA and T1D.

15 Sep 2023

Is there an association between waist-calf circumference ratio and all-cause and cause-specific mortality?

How anthropometric measures like WCR are associated with cause-specific and all-cause mortality in elderly adults.

15 Sep 2023

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

The effectiveness of a novel monovalent recombinant protein vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2023

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

The monkeypox (mpox) virus has caused worldwide transmission since its initial report in England in early May 2022.

15 Sep 2023

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Researchers discover that antiviral lectins like BOA can effectively inhibit SARS-CoV-2 and its variants by targeting spike glycans, opening doors for potential pan-coronavirus treatments. The study reveals that BOA's multivalent interactions make it a potent inhibitor against a range of viral variants, offering promise for future therapeutic strategies.

14 Sep 2023

Past infections may shape your COVID booster's punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

14 Sep 2023

Impact of prior SARS-CoV-2 infection and mRNA vaccination on contagiousness and infection risk

The study finds that natural SARS-CoV-2 infection offers stronger immunity against the virus compared to mRNA vaccines. However, mRNA vaccines significantly reduce the infectiousness of individuals with COVID-19, playing a crucial role in limiting the virus's transmission.

14 Sep 2023

CDC awards $8.7 million to train and educate vector-borne disease professionals

To help respond to emerging and established vector-borne threats, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD), led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention (CDC) to train and educate current and future vector-borne disease professionals and to evaluate the effectiveness of community and regional prevention strategies.

14 Sep 2023

TU Dresden researchers develop highly innovative solutions for the detection of viral pathogens

The outbreak of the COVID pandemic in 2020 has once again shown how important reliable and rapid detection methods are to initiate effective measures to combat a pandemic.

14 Sep 2023

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

The next phase of the study will be known as SIREN 2.0 and began in September 2023.

14 Sep 2023

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.

14 Sep 2023

Geographic disparities in breast cancer mortality: how where you live could matter

A new paper recently published in JAMA Network Open explores the differential mortality rates across various US counties regarding their geographic location associated with multiple sociodemographic factors.

14 Sep 2023

Multi-omics study offers insights into psoriasis treatment

Researchers use a multi-omics approach combining immune cell-enriched scRNA-seq, microarray analysis, and immunohistochemistry to elucidate the translational role of anti-IL-17A in suppressing the autoimmune functions of T17 cells, thereby effectively treating human psoriasis.

14 Sep 2023

Reviving reservoirs: new findings shake up HIV treatment understanding

Researchers provide insight into the interaction between T lymphocytes and persisting reservoirs of HIV, with repercussions for harnessing effective, long-lasting responses to HIV eradication.

14 Sep 2023

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

Researchers designed and evaluated a multi-epitope vaccine targeting the main outer membrane protein of Chlamydia pneumoniae using immunoinformatics.

14 Sep 2023

Disease/Infection News

Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

A comprehensive analysis of first monkeypox outbreak in Shenzhen, China

How does Helicobacter pylori infection influence rheumatoid arthritis?

Can upper respiratory tract specimens be used to diagnose Tuberculosis?

A new covid booster is here. Will those at greatest risk get it?

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Is there an association between waist-calf circumference ratio and all-cause and cause-specific mortality?

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Past infections may shape your COVID booster's punch against Omicron

Impact of prior SARS-CoV-2 infection and mRNA vaccination on contagiousness and infection risk

CDC awards $8.7 million to train and educate vector-borne disease professionals

TU Dresden researchers develop highly innovative solutions for the detection of viral pathogens

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

Geographic disparities in breast cancer mortality: how where you live could matter

Multi-omics study offers insights into psoriasis treatment

Reviving reservoirs: new findings shake up HIV treatment understanding

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News